Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Swartz, M. S. Articles by Hannon, M. J. Search for Related Content PubMed Citation Articles by Swartz, M. S. Articles by Hannon, M. J. Addictive Disorders (General) Schizophrenia Spectrum Disorders

Detection of Illicit Substance Use Among Persons With Schizophrenia by Radioimmunoassay of Hair

OBJECTIVE: Illicit substance use is a potent risk factor for poor outcomes in schizophrenia, yet methods for detecting substance use consistently underestimate the problem. The purpose of this study was to assess whether use of a relatively new method of detection, radioimmunoassay of hair, improved detection and was acceptable to patients with serious mental illness. METHODS: Persons already participating in a longitudinal naturalistic study of schizophrenia treatment were approached for participation in this study. The 203 persons who consented were interviewed and submitted urine and hair samples for laboratory measures of potential substances of abuse. Radioimmunoassay of hair was used to detect the use of amphetamines, cocaine, marijuana, opiates, and phencyclidine (PCP) in the preceding three months. RESULTS: Of the 203 participants, only 33 (16.3 percent) self-reported illicit substance use, and only 25 (12.4 percent) had a positive urine test, but 63 (31.0 percent) had a positive hair assay. When all detection methods were combined—self-report, urine test, and hair assay—78 participants (38.4 percent) were classified as users in the preceding three months. Few of those asked to participate (20, or 9.9 percent) refused hair analysis. CONCLUSIONS: Radioimmunoassay of hair appears to be a promising method for improving assessment of illicit substance use among persons with schizophrenia. Most participants appeared to find hair analysis an acceptable procedure, although this conclusion warrants further study. The test's three-month window of detection may make it a valuable method for assessing and monitoring use over time.

This article has been cited by other articles:

				I. Kooyman, K. Dean, S. Harvey, and E. Walsh Outcomes of public concern in schizophrenia The British Journal of Psychiatry, August 1, 2007; 191(50): s29 - s36. [Abstract] [Full Text] [PDF]

				M. F. Brunette, R. E. Drake, H. Xie, G. J. McHugo, and A. I. Green Clozapine Use and Relapses of Substance Use Disorder Among Patients With Co-occurring Schizophrenia and Substance Use Disorders Schizophr Bull, October 1, 2006; 32(4): 637 - 643. [Abstract] [Full Text] [PDF]

				B. GREEN, R. YOUNG, and D. KAVANAGH Cannabis use and misuse prevalence among people with psychosis The British Journal of Psychiatry, October 1, 2005; 187(4): 306 - 313. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2003 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us